Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval

Japan’s Shionogi & Co Ltd https://www.reuters.com/companies/4507.T” target=”_blank” rel=”noopener”>(4507.T) believes its COVID-19 pill will easily garner $2 billion in annual sales if it secures U.S. approval, which the company expects to receive in late 2024, …
Read More

What's Hot

Business Maverick: China industrial profits drop on weak demand, falling prices

No ‘decoupling’ here: Apple, Samsung, and Qualcomm sing China’s praises

Covid-19: India reports 1,805 new cases in 24 hours; daily positivity rate at 3.19 per cent

Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval | Reuters

Business Maverick: China industrial profits drop on weak demand, falling prices

No ‘decoupling’ here: Apple, Samsung, and Qualcomm sing China’s praises

Covid-19: India reports 1,805 new cases in 24 hours; daily positivity rate at 3.19 per cent

New downtown exhibit compares Winnipeg’s COVID-19 response to the Spanish Flu

Business Maverick: China industrial profits drop on weak demand, falling prices

No ‘decoupling’ here: Apple, Samsung, and Qualcomm sing China’s praises

Covid-19: India reports 1,805 new cases in 24 hours; daily positivity rate at 3.19 per cent

New downtown exhibit compares Winnipeg’s COVID-19 response to the Spanish Flu

Covid returns? India reports highest daily cases in nearly five months; active cases at 9,433

Wastewater could be used to track more viruses than COVID-19

Police require protesters to wear number badges

Cameron Toshack interview: What really happened at Leeds United, dad’s Covid fight and my Swansea City pride

A message to our readers: we’re here to stay

Anubhav Sinha: Showing lockdown-Partition similarities 'deeply personal'

What's Hot

Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval | Reuters

Related Posts